The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase.EBI
Martin-Luther-University Halle-Wittenberg
Repurposing N,N'-bis-(arylamidino)-1,4-piperazinedicarboxamidines: An unexpected class of potent inhibitors of cholinesterases.EBI
Martin-Luther-University Halle-Wittenberg
Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studies.EBI
Martin-Luther-University Halle-Wittenberg
Discovery of 4-anilinoa-carbolines as novel Brk inhibitors.EBI
Martin-Luther-University Halle-Wittenberg
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.EBI
Martin-Luther-University Halle-Wittenberg
Multitargeted drug development: Discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting Alzheimer disease relevant kinases.EBI
Martin-Luther-University Halle-Wittenberg
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.EBI
Martin-Luther-University Halle-Wittenberg
Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties.EBI
Martin-Luther-University Halle-Wittenberg
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1.EBI
Martin-Luther-University Halle-Wittenberg
In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase.EBI
Martin-Luther-University Halle-Wittenberg
Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1).EBI
Martin-Luther-University Halle-Wittenberg
Discovery and selectivity-profiling of 4-benzylamino 1-aza-9-oxafluorene derivatives as lead structures for IGF-1R inhibitors.EBI
Martin-Luther-University Halle-Wittenberg
Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis.EBI
Martin-Luther-University Halle-Wittenberg
Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.EBI
Martin-Luther-University Halle-Wittenberg
Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors.EBI
Martin-Luther-University Halle-Wittenberg
Caffeic acid phenethyl ester (CAPE)-derivatives act as selective inhibitors of acetylcholinesterase.EBI
Martin-Luther-University Halle-Wittenberg
Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1.EBI
Martin-Luther-University Halle-Wittenberg
Evidence for the absolute conformational specificity of the intestinal H+/peptide symporter, PEPT1.EBI
Martin-Luther-University Halle-Wittenberg
A novel inhibitor of the mammalian peptide transporter PEPT1.EBI
Martin-Luther-University Halle-Wittenberg
Unexpected AChE inhibitory activity of (2E)α,β-unsaturated fatty acids.EBI
Martin-Luther-University Halle-Wittenberg
Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II.EBI
Martin-Luther-University Halle-Wittenberg
Potent and Selective Inhibitors of Human Sirtuin 5.EBI
Martin-Luther-University Halle-Wittenberg
Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors.EBI
Martin-Luther-University Halle-Wittenberg
Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.BDB
Upjohn